Overview

A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People

Status:
Recruiting
Trial end date:
2021-12-04
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the effects of delgocitinib, taken as a capsule, on the heart rhythms of healthy people, compared to a placebo.
Phase:
Early Phase 1
Details
Lead Sponsor:
LEO Pharma